Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Industry Summary Page

Industry: pharmaceuticals
Penalty Total since 2000: $116,245,163,450
Number of Records: 1,270
Note: The totals include only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. The totals are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.
Top 10 Current Parent CompaniesTotal Penalty $Number of Records
Johnson & Johnson$24,497,162,77088
Pfizer$10,948,368,52398
Merck$10,710,400,03189
Teva Pharmaceutical Industries$10,242,576,79696
GlaxoSmithKline$9,572,803,40650
Purdue Pharma$9,278,372,78711
AbbVie$7,560,456,40484
Takeda Pharmaceutical$3,987,516,44732
Endo International$3,311,990,66730
Eli Lilly$2,831,299,67626

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyCurrent ParentPrimary Offense Type sort iconYearAgencyPenalty Amount
Pfizer Inc.Pfizerprice-fixing or anti-competitive practices2018private lawsuit-federal$94,000,000
Pfizer Inc.Pfizerprice-fixing or anti-competitive practices2021private lawsuit-federal$345,000,000
Pharmacia CorporationPfizerprice-fixing or anti-competitive practices2011private lawsuit-federal$9,615,384
Purdue Pharma L.P.Purdue Pharmaprice-fixing or anti-competitive practices2010private lawsuit-federal$16,000,000
Ranbaxy Laboratories Ltd.Sun Pharmaceuticalsprice-fixing or anti-competitive practices2020private lawsuit-federal$3,500,000
Ranbaxy, Inc.Sun Pharmaceuticalsprice-fixing or anti-competitive practices2022private lawsuit-federal$485,000,000
Sandoz Inc.Sandoz Groupprice-fixing or anti-competitive practices2017private lawsuit-federal$1,750,000
Sandoz Inc.Sandoz Groupprice-fixing or anti-competitive practices2017private lawsuit-federal$3,202,500
Sandoz Inc.Sandoz Groupprice-fixing or anti-competitive practices2020private lawsuit-federal$85,000,000
Sandoz Inc.Sandoz Groupprice-fixing or anti-competitive practices2011private lawsuit-federal$150,000,000
Sanofi Pasteur Inc.Sanofiprice-fixing or anti-competitive practices2017private lawsuit-federal$61,500,000
Schering-Plough CorporationMerckprice-fixing or anti-competitive practices2009private lawsuit-federal$55,000,000
Shire LLCTakeda Pharmaceuticalprice-fixing or anti-competitive practices2022private lawsuit-federal$1,850,000
Shire US Inc.Takeda Pharmaceuticalprice-fixing or anti-competitive practices2016private lawsuit-federal$14,750,000
Sun Pharmaceuticals Industries LtdSun Pharmaceuticalsprice-fixing or anti-competitive practices2019private lawsuit-federal$400,000
Sun Pharmaceuticals Industries LtdSun Pharmaceuticalsprice-fixing or anti-competitive practices2023private lawsuit-federal$17,357,000
Takeda ChemicalTakeda Pharmaceuticalprice-fixing or anti-competitive practices2000private lawsuit-federal$22,000,000
Takeda Chemical Industries Ltd.Takeda Pharmaceuticalprice-fixing or anti-competitive practices2003private lawsuit-federal$22,000,000
TAP Pharmaceutical ProductsTakeda Pharmaceuticalprice-fixing or anti-competitive practices2005private lawsuit-federal$150,000,000
Taro Pharmaceutical USA Inc.Sun Pharmaceuticalsprice-fixing or anti-competitive practices2023private lawsuit-federal$67,643,000
Teva Pharmaceuticals USA Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2015private lawsuit-federal$512,000,000
Teva Pharmaceuticals USA Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2018private lawsuit-federal$27,000,000
Teva Pharmaceuticals USA Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2017private lawsuit-federal$73,000,000
Teva Pharmaceuticals USA Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2015private lawsuit-federal$24,000,000
UCB Chemicals CorporationUCBprice-fixing or anti-competitive practices2001private lawsuit-federal$9,000,000
Valeant Pharmaceuticals International, Inc.Bausch Healthprice-fixing or anti-competitive practices2022private lawsuit-federal$23,000,000
Valeant Pharmaceuticals International, Inc.Bausch Healthprice-fixing or anti-competitive practices2012private lawsuit-federal$37,500,000
Valeant Pharmaceuticals International, Inc.Bausch Healthprice-fixing or anti-competitive practices2013private lawsuit-federal$11,750,000
Warner ChilcottAbbVieprice-fixing or anti-competitive practices2015private lawsuit-federal$8,000,000
Warner Chilcott Holdings CompanyAbbVieprice-fixing or anti-competitive practices2008private lawsuit-federal$9,000,000
Warner Chilcott Holdings CompanyAbbVieprice-fixing or anti-competitive practices2007private lawsuit-federal$4,150,000
Warner Chilcott Holdings CompanyAbbVieprice-fixing or anti-competitive practices2007private lawsuit-federal$2,100,000
Watson LaboratoriesTeva Pharmaceutical Industriesprice-fixing or anti-competitive practices2016private lawsuit-state$50,000,000
Watson Pharmaceuticals, Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2011private lawsuit-federal$9,615,384
Watson Pharmaceuticals, Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2011private lawsuit-federal$27,000,000
Watson Pharmaceuticals, Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2012private lawsuit-federal$79,000,000
Wockhardt LimitedWockhardt Limitedprice-fixing or anti-competitive practices2019private lawsuit-federal$340,000
WyethPfizerprice-fixing or anti-competitive practices2005private lawsuit-federal$2,100,000
ZLB Behring, L.L.C.CSL Limitedprice-fixing or anti-competitive practices2011private lawsuit-federal$9,615,384
Johnson & JohnsonJohnson & Johnsonprice-fixing or anti-competitive practices2023private lawsuit-federal$25,000,000
Forest Laboratories LLCAbbVieprice-fixing or anti-competitive practices2023private lawsuit-federal$27,200,000
Indivior Inc.Indivior PLCprice-fixing or anti-competitive practices2023MULTI-AG$102,500,000
GlaxoSmithKlineGlaxoSmithKlineprice-fixing or anti-competitive practices2023IN-AG$1,270,000
Novartis AGNovartisprice-fixing or anti-competitive practices2023private lawsuit-federal$126,850,000
Teva Pharmaceuticals USA, Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2023DOJ_ANTITRUST$275,000,000
Glenmark Pharmaceuticals Inc., USAGlenmark Pharmaceuticalsprice-fixing or anti-competitive practices2023DOJ_ANTITRUST$30,000,000
Novartis Pharmaceuticals CorporationNovartisprice-fixing or anti-competitive practices2023private lawsuit-federal$30,000,000
MerckMerckprice-fixing or anti-competitive practices2023private lawsuit-federal$56,000,000
Glenmark PharmaceuticalsGlenmark Pharmaceuticalsprice-fixing or anti-competitive practices2023private lawsuit-federal$14,000,000
Indivior Inc.Indivior PLCprice-fixing or anti-competitive practices2023private lawsuit-federal$30,000,000
Gilead SciencesGilead Sciencesprice-fixing or anti-competitive practices2024private lawsuit-federal$246,750,000
Indivior Inc.Indivior PLCprice-fixing or anti-competitive practices2024private lawsuit-federal$385,000,000
Endo Health Solutions Inc.Endo Internationaloff-label or unapproved promotion of medical products2014FDA$192,700,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2013FDA$2,200,000,000
Wyeth Pharmaceuticals Inc.Pfizeroff-label or unapproved promotion of medical products2013FDA$490,900,000
Par Pharmaceutical Companies Inc.Endo Internationaloff-label or unapproved promotion of medical products2013FDA$45,000,000
GlaxoSmithKline LLCGlaxoSmithKlineoff-label or unapproved promotion of medical products2012FDA$3,000,000,000
Abbott Laboratories Inc.AbbVieoff-label or unapproved promotion of medical products2012FDA$1,500,000,000
Cypress Pharmaceutical Inc.Currax Pharmaceuticalsoff-label or unapproved promotion of medical products2012FDA$2,800,000
Merck, Sharp & DohmeMerckoff-label or unapproved promotion of medical products2011FDA$950,000,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2011FDA$14,500,000
Scios Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2011FDA$85,000,000
Novo Nordisk Inc.Novo Holdings A/Soff-label or unapproved promotion of medical products2011FDA$25,000,000
UCB Inc.UCBoff-label or unapproved promotion of medical products2011FDA$34,000,000
Forest Pharmaceuticals Inc.AbbVieoff-label or unapproved promotion of medical products2011FDA$164,000,000
Elan Corporation PLCPerrigooff-label or unapproved promotion of medical products2010FDA$203,000,000
Eisai Inc.Eisaioff-label or unapproved promotion of medical products2010FDA$11,000,000
Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010FDA$422,500,000
Allergan Inc.AbbVieoff-label or unapproved promotion of medical products2010FDA$600,000,000
Ortho-McNeil Pharmaceutical LLCJohnson & Johnsonoff-label or unapproved promotion of medical products2010FDA$81,000,000
AstraZeneca LPAstraZenecaoff-label or unapproved promotion of medical products2010FDA$520,000,000
Amgen Inc.Amgenoff-label or unapproved promotion of medical products2012FDA$762,000,000
Inspire Pharmaceuticals Inc.Merckoff-label or unapproved promotion of medical products2015USAO$5,900,000
Warner Chilcott PLCAbbVieoff-label or unapproved promotion of medical products2015FDA$125,000,000
Shire Pharmaceuticals LLCTakeda Pharmaceuticaloff-label or unapproved promotion of medical products2014FDA$56,500,000
Boehringer Ingelheim Pharmaceuticals Inc.Boehringer Ingelheimoff-label or unapproved promotion of medical products2012FDA$95,000,000
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010FDA$72,500,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2009FDA$2,300,000,000
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2009FDA$1,415,000,000
Cephalon IncTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2008FDA$425,000,000
Otsuka American Pharmaceutical Inc.Otsuka Pharmaceuticaloff-label or unapproved promotion of medical products2008FDA$4,000,000
Bristol-Myers Squibb CompanyBristol-Myers Squibboff-label or unapproved promotion of medical products2007DOJ_CIVIL$515,000,000
Medicis Pharmaceutical CorporationBausch Healthoff-label or unapproved promotion of medical products2007DOJ_CIVIL$9,800,000
Serono, S.A.Merck KGaA (EMD)off-label or unapproved promotion of medical products2005FDA$704,000,000
Warner-LambertPfizeroff-label or unapproved promotion of medical products2004FDA$430,000,000
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2005FDA$36,000,000
InterMune Inc.Rocheoff-label or unapproved promotion of medical products2006FDA$36,900,000
Janssen Pharmaceuticals, Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2013USAO$410,000,000
Jazz Pharmaceuticals Inc.Jazz Pharmaceuticalsoff-label or unapproved promotion of medical products2007USAO$20,000,000
Schering-Plough CorporationMerckoff-label or unapproved promotion of medical products2006USAO$435,000,000
Abbott LaboratoriesAbbott Laboratoriesoff-label or unapproved promotion of medical products2018USAO$25,000,000
Abbott LaboratoriesAbbVieoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $339,148,643
Allergan Inc.AbbVieoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $14,750,000
Amgen Inc.Amgenoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $612,000,000
Amgen Inc.Amgenoff-label or unapproved promotion of medical products2015MULTI-AG$71,000,000
AstraZenecaAstraZenecaoff-label or unapproved promotion of medical products2013KY-AG$5,500,000
AstraZeneca PharmaceuticalsAstraZenecaoff-label or unapproved promotion of medical products2011MULTI-AG$68,500,000
AstraZeneca Pharmaceuticals LPAstraZenecaoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993
Boehringer Ingelheim Pharmaceuticals, Inc.Boehringer Ingelheimoff-label or unapproved promotion of medical products2017MULTI-AG$13,500,000
Boehringer-Ingelheim Pharmaceuticals, Inc.Boehringer Ingelheimoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $95,000,000
Bristol-Myers SquibbBristol-Myers Squibboff-label or unapproved promotion of medical products2016MULTI-AG$19,500,000
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.